Effects On The Side
🚨 Once hailed as a beacon of hope against COVID-19, Remdesivir's past and present tell a more troubling story. In this episode of Effects on the Side, we delve into: The drug's alarming 53% mortality rate in Ebola trials. Its rapid endorsement during the pandemic despite questionable efficacy. Investigations into financial ties influencing its promotion. The ethical implications of prioritizing profit over patient safety. 🔎 Join us as we uncover the complex web behind Remdesivir and what it means for future medical interventions. 🎙️ Listen now on Effects on the Side.
16 Episoder
Kommentarer
0Vær den første til å kommentere
Registrer deg nå og bli medlem av Effects On The Side sitt community!